News | Digital Pathology | September 22, 2022

INFINITT North America, an award-winning developer of enterprise imaging solutions for healthcare, announced a collaboration with Hamamatsu Corporation to jointly promote Hamamatsu whole slide scanners (NanoZoomers*) and Infinitt Digital Pathology Solution (IDPS) to its United States customers. 

Each therapeutic seed, approximately the size of a postage stamp, contains radiation

Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare, announced a collaboration with Hamamatsu Corporation to jointly promote Hamamatsu whole slide scanners (NanoZoomers*) and Infinitt Digital Pathology Solution (IDPS) to its United States customers. 


September 22, 2022 — By partnering with Hamamatsu, Infinitt can offer an enhanced integration with NanoZoomers, enabling laboratories and pathologists to seamlessly review slides in an end-to-end operational workflow. Further, the ability of IDPS to integrate with LIS will allow pathologists to work more efficiently in a digital environment. 

Hamamatsu’s NanoZoomer series of whole slide scanners have been developed with almost 70 years of experience in photonics. IDPS allows scanned images to be analyzed by advanced digital and computational tools and enables rapid communication with multiple users for a second opinion or multi-disciplinary team (MDT) review. 

As laboratories adopt digital pathology, they must leverage a complex hardware and software solutions ecosystem to facilitate pathologists' workflow. In addition, these laboratories are now recognizing that the image quality, flexibility, and reliability of the whole slide scanners are critical to helping users get over the adoption chasm within the organization. 

According to Don Ariyakumar, Product Manager at Hamamatsu, interoperability is key to the success of the adoption of digital pathology, so working with partners is very important for organizations such as Hamamatsu. Don, additionally acknowledges that the customers should be able to build the best-of-breed products for their organizations. 

Hamamatsu and Infinitt bring together Hamamatsu's NanoZoomer whole slide scanners with Infinitt 's enterprise platform to manage images, data, and algorithms to streamline pathology workflows. 

“Infinitt is excited to be part of the digital revolution in pathology,” said David Smarro, President and CEO of Infinitt North America, “and to collaborate with a leading photonics company to promote solutions to our customer base.” 

There are many benefits to be realized with digital pathology, including increased productivity in the lab and less risk of damaged slides or lost specimens. Combining digitization with AI and computational tools can facilitate faster and more efficient workflow.” 

IDPS works with the Infinitt Healthcare Platform which can archive data from different data sources and departments, enabling pathologists to view images and reports from multiple specialties. It is a true enterprise solution, complementing our extensive line of specialty and universal viewers that work with almost any LIS or EMR,” added Smarro. 

*Hamamatsu NanoZoomers are sold for research use only 

For more information: www.infinittna.com 


Related Content

News | Radiology Education

October 5, 2022 — DetectedX announced today that it will provide free access to its Radiology Online Learning Centre to ...

Time October 05, 2022
arrow
Feature | Radiology Business

Here is a recap of what ITN viewers found most interesting during the month of September: 1. Lasting Lung Damage Seen in ...

Time October 03, 2022
arrow
Feature | Radiology Imaging

View the September/October digital edition of Imaging Technology News (ITN), including links to videos, comparison ...

Time September 29, 2022
arrow
News | Enterprise Imaging

September 27, 2022 — Intelerad Medical Systems, a leading global provider of enterprise imaging solutions, announced its ...

Time September 27, 2022
arrow
News | Radiation Oncology

September 26, 2022 — Cleveland Clinic received a $7.9 million five-year grant from the National Cancer Institute at the ...

Time September 26, 2022
arrow
News | Contrast Media

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
News | Digital Pathology

September 21, 2022 — By partnering with Hamamatsu, Infinitt can offer an enhanced integration with NanoZoomers, enabling ...

Time September 21, 2022
arrow
Feature | Digital Pathology | By Michael Valante

With digital pathology now being adopted by institutions around the globe, it is not surprising that we are seeing a ...

Time September 21, 2022
arrow
News | RSNA

September 16, 2022 — The Radiological Society of North America (RSNA) has announced Technical Exhibits highlights for ...

Time September 16, 2022
arrow
News | ASTRO

September 15, 2022 — On behalf of the nation's radiation oncologists and the more than one million people with cancer ...

Time September 15, 2022
arrow
Subscribe Now